亚色视频

News & Announcements听

听
Toledo Cancer Research Symposium showcases regional collaboration and innovation

听

The Department of Cell and Cancer Biology recently hosted the听Toledo Cancer Research Symposium, bringing together researchers, clinicians and students from 兔子先生传媒文化作品 and across Northwest Ohio to share cutting-edge cancer research and foster collaboration.

The full-day event featured 20 oral presentations and 54 posters, covering topics such as tumor biology, drug resistance, cancer epigenetics, clinical perspectives and artificial intelligence. Nearly 165 attendees including medical, graduate and undergraduate students, residents, and faculty participated in the symposium.

听

Welcome remarks were delivered by听Dr. Imran Ali, Dean of the College of Medicine and Life Sciences, who highlighted the rising cancer incidence in Northwest Ohio and the need for continued research. Provost听Dr. Mitchell McKinney听emphasized the importance of cross-campus, interdisciplinary collaboration in tackling cancer.

A major highlight was the keynote lecture by听Dr. Peter A. Jones, President and Chief Scientific Officer of the Van Andel Research Institute and an award-winning member of the National Academy of Sciences. A pioneer in cancer epigenetics, Dr. Jones shared insights into how epigenetic discoveries can lead to clinical breakthroughs.

The symposium demonstrated the strength of the region鈥檚 cancer research community and the University鈥檚 commitment to translating scientific advances into better outcomes for patients. This event was organized by a committee led by听Dr. Srinivas Vinod Saladi听and sponsored by Dr. Rizk, Dr. Manning, COMLS, College of Natural Sciences and Mathematics, several academic departments at 兔子先生传媒文化作品 and biotech companies.
Dean's Update: Monday, Sept. 2, 2025

Visit the symposium website

Department of Cell & Cancer Biology welcomes new faculty

Yong Jiang, Ph.D. has joined our faculty as an Associate Professor from East Tennessee State University, Quillen College of Medicine. Dr. Jiang鈥檚 research focuses on the tumorigenesis regulated by TGF-脽 and Wnt signaling pathways. Recently, his research group has been investigating the function and mechanism of the newly discovered protein kinase DSTYK in epithelial-to-mesenchymal transition (EMT) and treatment resistance, including both chemoresistance and immunotherapy resistance. In parallel, the team is engineering exosomes as targeted delivery vehicles to enhance therapeutic efficacy while minimizing off-target effects. These studies aim to identify novel therapeutic targets for cancer treatment and to develop exosome-based drug delivery systems capable of selectively targeting cancer cells鈥攑otentially transforming future cancer therapies.

Augustine Kwabil, 4th year Cell & Cancer Biology Student Publishes an Article in the Toledo Blade

鈥淔or patients, the promise of dormancy research is not only about living longer, but also about living better. Most people imagine that听beating cancer means making it vanish. But what if beating cancer also means learning to live peacefully with it? That idea is powerful. After all, cancer cells are not strangers; they are from our own bodies.鈥�

Augustine Kwabil, a Ph.D. student in the Cell and Cancer Biology track of our Biomedical Science Program, wrote a column in the听Toledo Blade听sharing his research on prostate cancer. He is conducting his research in the laboratory of听Dr. Xiaohong Li听in the Department of Cell and Cancer Biology.


Dean's Update: Monday, Oct. 13, 2025

4th Year Cell & Cancer Biology Student, Rejina Shrestha, Publishes an Article in the Toledo Blade

鈥淲hat makes pancreatic cancer so devastating is not just how silently cancer cells multiply, but how aggressively these cells defend themselves. Pancreatic cancer cells can survive in toxic environments; situations where even other cancers would struggle, and all the normal cells would die. This unusual quality makes pancreatic cancer one of the hardest forms of cancer to treat.鈥�

Rejina Shrestha, a Ph.D. student in the Cell and Cancer Biology track of our Biomedical Science Program, wrote a column in the听Toledo Blade听sharing her research on pancreatic cancer. She is conducting her research in the laboratory of听Dr. Kuo-hui Su听in the Department of Cell and Cancer Biology.


Dean's Update: Monday, Sept. 2, 2025

3rd Year Cell & Cancer Biology Student, Azeezat Osikoya, Publishes an Article in Toledo Blade听 听

Azeezat Osikoya, is a Ph.D. student in the Cell and Cancer Biology track of our Biomedical Science Program. She recently wrote a column in the Toledo Blade sharing her research into a protein that plays a key role in the progression of triple-negative breast cancer. She is conducting her research in the laboratory of Dr. Dayanidhi Raman.听

Our ongoing research goal is to better understand how eIF4A1 influences cancer progression and whether targeting it could weaken cancer cells ability to adapt and survive. By understanding the mechanisms that breast cancer stem-like cells rely on eIF4A1 for survival and growth in triple-negative brest cancer, we will pave the way for more effective cancer treatment."听

Dean's Update: Monday, March 3, 2025

Congratulations to Dr. Deepti Gurung


Ms. Deepti Gurung听successfully defended her dissertation for the Ph.D. degree on July 15, 2025. Her dissertation, entitled 鈥淎 Mechanistic Study to Understand the Differential Conformational Dyanmics of 14-3-3 Proteins Towards the Development of Isoform-Specific Cancer Therapeutics,鈥� was completed under the mentorship of Dr. JingYuan Jasmine Liu. Congratulations Dr. Gurung and we wish you well in your future endeavors!

Congratulations to Dr. Shruti Ghai


On December 5, 2024, Ms. Shruti Ghai successfully defended her dissertation for her PhD degree. The dissertation was entitled "HSF1 inhibition induces pancreatic ductal adenocarcinoma autophagy through JNK". Dr. Ghai has been mentored by Dr. Kuo-Hui Su. Congratulations Shruti and best of luck in your future endeavors!

Congratulations to Azeezat Osikoya

Azeezat Osikoya has been selected as the recipient of the Three Minute Thesis (3MT庐) People's Choice Award on November 21st. Azeezat was voted by her peers and judges. The 7th annual Three minute Thesis (3MT庐) competition听is an academic competition during which students must effectively explain their graduate research in three minutes or less to an audience of specialists and non-specialists alike.

For more details:听Graduate Student Success:听The Three Minute Thesis (3MT庐)

听

2024 Larry Gentry Research Forum

听

Under the sponsorship of The Department of Cell & Cancer Biology, the 2024 Dr. Larry Gentry Research Forum was held on October 24, 2024 in Lancelot Thompson Student Union on the main campus of the University of Toledo. This annual event included presentations by 11 graduate students and 4 postdocs.听Keynote speaker and 2012 alumni was Dr. Sanjeevani Arora, Assistant Professor of Cancer Prevention and Control Program, Fox Chase Cancer Center in Philadelphia, PA. Her presentation was entitled "Biomarkers of Therapeutic Response in Recal Cancer: Toward Precision Medicine." 听Dr. Arora was able interact with Cell and Cancer Biology students providing advice in research development and their future careers.

Awards Winners:

Shruti Ghai - winner of 2024 Dr. Maurice Manning Outstanding Student award, presented by Dr. Maurice Manning
Dr. Sophia Josephraj - winner of the 2024 Postdoc Fellow Excellence award, presented by Dr. Ivana de la Serna

New Faculty join Dept. of Cell & Cancer Biology

The department wishes to welcome Dr. Srinivas Vinod Saladi and Dr. Jianmin Zhang to our faculty.

Dr. Saladi joins us as an Assistant Professor from Massachusetts General Hospital/Harvard Medical School, Department of Otolaryngology Head and Neck Surgery. His research interests primarily focus on understanding the mechanism by which epigenetic reprogramming contributes to cellular plasticity in tumors. To define the mechanisms in which deregulated chromatin remodeling or altered chromatin landscape act as oncogenic drivers in cancer. Epigenetic reprogramming is a key oncogenic driver event in multiple cancers, however, very little is known about the deregulated epigenetic programs in head and neck squamous cell carcinomas.

Dr. Zhang joins us as a Professor from the Roswell Park Comprehensive Cancer Center, Department of Cancer Genetics & Genomics. His research interest is in genetic and epigenetic alterations in breast tumorigenesis and metastasis. Specifically, on elucidating genetic alterations in the Hippo signaling pathway, as well as the role of epithelial-to-mesenchymal transition (EMT) and cancer stem/progenitor cell self-renewal in breast cancer progression and metastasis.

听

听

兔子先生传媒文化作品 Participates in Tri-University Breast Cancer Research Retreat at Maumee Bay


Jian-Ting Zhang was an organizer for the Tri-University Breast Cancer Research Retreat at Maumee Bay State Park in Oregon, Ohio, in June. This event was hosted by 兔子先生传媒文化作品, Karmanos Cancer Institute at Wayne State University, and The University of Cincinnati College of Medicine.

During the retreat, the Department of Cell and Cancer Biology had three speakers present their current research: Dr. Dayanidhi Raman, Dr. Kam Yeung,听and Dr. Jianmin Zhang. There were also three poster presentations: one from Dr. Raman鈥檚 lab and two from Dr. Zhang鈥檚 lab, which David Escobar won 2nd place. Dr. Yue Zou was a co-chair for one of the sessions and Dr. Jason Su was one of six judges for the poster competition.听 (Dean's Update,7/15/24)

Dr. Yue Zou Receives 2024-2025 Bridge Funding Award听 听 听 听 听 听 听 听

Dr. Yue Zou, Professor of Cell & Cancer Biology, has received bridge funding from the College of Medicine & Life Sciences. The听funding was awarded for his outstanding research and potential for future funding. Dr. Zou鈥檚 project, 鈥淎TR Isomerization-Based Mitochondrial Apoptosis Priming in Cancer and Therapeutic Resistance,鈥� will receive bridge funding to investigate the role of mitochondrial ATR in oncogenesis and apoptosis. Dr. Zou discovered that ATR exists in two different isoforms: a nuclear form involved in DNA damage signaling 听and a mitochondrial form that contributes to oncogenesis and therapeutic resistance by binding to tBid. This funding will help address reviewer鈥檚 concerns on his R01 application.

Faculty Recognition

Dr. JianTing Zhang, Endowed Chair of Biochemistry and Cell & Cancer Biology recently received Outstanding Research and Scholarship Award. He is recognized as an international academic leader in the field of therapeutic resistance biology and drug discovery. The impact of Zhang鈥檚 productive scholarship is reflected by his more than 140 publications and his inventions, with five approved patents and a successful clinical trial based on his discoveries. Zhang has been recognized nationally and internationally. He was invited to serve as the inaugural Editor-in-Chief for the International Journal of Biochemistry and Molecular Biology, a rare honor only reserved for highly regarded academic scholars.

In 2021, Zhang was elected as Fellow of American Association for the Advancement of Science (AAAS), the world鈥檚 largest multidisciplinary scientific society. His recognition also includes the sustained federal grant support of his high impact research program for the past 30 years, making him the second current AAAS Fellow at The University of Toledo.听(UT News, 4/30/24)

In addition, 兔子先生传媒文化作品 Board of Trustees recently approved tenure for Dr. Xiaohong Li, Associate Professor of Cell & Cancer Biology, and Dr. Jasmine Liu was approved for promotion to Professor of Medicine and Cell & Cancer Biology.听 Congratulations to all!

Department Research Awards

Congratulations to Dr. Xiaohong Li and Dr. Shang Su on their recent grant awards:
Dr. Li:
听 - 3 year grant from the Dept. of Defence, "Dormancy mimicking to inhibit prostate cancer metastasis and recurrence"
听 - 1 year award from the U.S. Army Medical Research and Development Command听 "Developing PTH1R PROTAC degraders for lethal
听 听 听prostate cancer"
Dr. Su:
听 - 2 year award from the Dept. of Defense "Dabber: D-Type Peptide Grabber for Degradation of Undruggable Transcription Factors in听
听 听 Lethal Prostate Cancer"

Deepti Gurung Recipient of GSA Graduate Research Award for Academic Year 2023-2024

Fifth year BMSP student, Deept Gurung, has been awarded a 2023-2024 Graduate Student Association Research Award. She received $2200 in financial support for costs associated with her research project "Targeting dynamics of 14-3-3-饾瀭 for the treatment of pancreatic cancer".听 Deepti is advised by Dr. Jasmine Liu. Great job Deepti!

Cell and Cancer Biology Student Places Second at the 2024 Graduate Research Forum

Congratulations to Deepti Gurung, current PhD candidate in Dr. Jasmine Liu's lab, who tied in second place in the oral presentations at the Graduate Research Forum held March 21-22, 2024.听 Her talk was entitled "Probing protein dynamics and conformation transitions of 14-3-3 sigma for the treatment of pancreatic cancer."听听

Congratulations to Dr. Caoqinglong 'Jackson' Huang


On February 14, 2024, Dr. Huang successfully defended his dissertation for his PhD degree. The dissertation was entitled "Development of Improved Survivin Dimerization Inhbitiors for Castration-Resistant Prostate Cancer". Dr. Huang has been mentored by Dr. Jian-Ting Zhang. Congratulations Jackson and best of luck in your future endeavors!

Dr. Dayanidhi Raman Honored by Ohio Cancer Research with 2023 Discover Award

Congratulations to Dr. Dayanidhi Raman, Associate Professor, who was selected as the 2023 Ohio Cancer Research (OSR) Discover Awardee. This award recognizes OCR grantees who turn their pilot grant into major funding and successes in their research.

Dr. Raman received a $50,000 seed money grant from OCR in 2017 that generated nearly $3 million from other sources based on his success.

OCR has provided for $1.2 million in seed money to Toledo area researchers at the University of Toledo and Bowling Green State University, generating more than $87 million from other sources to continue work based on initial success.听
Dean's Update, Monday, November 21, 2023

Congratulations to 2023 Outstanding Postdoc and Student Research Awardees听 听
听 听 听 听 听 听 听 听 听 听 听 听 听 听 听 听
Congratulations to postdoc, Yibo Luo, Ph.D., and 5th year student, Deepti Gurung, on winning the 2023 Outstanding Postdoc and Student awards in Cell & Cancer Biology. Dr. Luo is a postdoctoral fellow in the laboratory of Dr. Yue Zou and Deepti is mentored by Dr. Jasmine Liu. They are pictured below with Dr. Ivana de la Serna, who chairs the award committee.听

听

2023 Larry Gentry Research Forum

The Biomedical Sciences Cell & Cancer Biology program held our annual research retreat, the Larry Gentry Research Forum, on Friday, October 27 at the Lancelot Thompson Student Union on the main campus of 兔子先生传媒文化作品.听 The Department of Cell & Cancer Biology sponsors this event each year, which is named after the late Dr. Larry Gentry, Associate Professor of Biochemistry & Molecular Biology. This event promotes scientific exchange among听 our students, postdoc fellows, faculty and keynote speakers. Importantly, our students interact with the guest speaker to learn their approach to a successful academic career. Featured were presentations from 13 students and postdoctoral fellows. The keynote speaker for 2023 program was our 2005 alumni, Yatrik Shah, Ph.D., Horace W. Davenport Collegiate Professor of Physiology, Professor of Molecular & Integrative Physiology and Professor of Internal Medicine, at the University of Michigan Medical School. He gave an stimulating seminar on "Gasses, Bugs and Lipids in Colon Cancer".听听

Dr. Raman on being recognized by the University of Toledo with the 2023 Basic Science Research Excellence Award!听

Dr. Dayanidhi Raman, Associate Professor of Cell & Cancer Biology, recently recognized as the 2023听 Basic Science Research Excellence Award.听Dr.听Raman was presented this award by Dr. Ivana de la Serna (nominator, left) and Dr. Christopher Cooper (right), Professor, Executive VP for Clinical Affairs and Dean, College of Medicine & Life Sciences. Dr. de la Serna wrote that he has 42 publications, and currently has four active grants. His research is at the forefront of breast cancer research, utilizes innovative approaches for improving therapeutics and touches upon important topics such as health disparities that are characteristic of this disease. His highly innovative and impactful research is recognized both nationally and internationally. Congratulations Dr. Raman on this well-deserved honor.

Dr. Shi-He Liu Awarded $2.5 million grant from NIH

Dr. Shi-He Liu, Assistant Professor of Cell & Cancer Biology, has received a five-year, $2.5 million R01 grant from the National Cancer Institute to advance his studies of targeted therapies for pancreatic cancer (PDAC).

His research focuses on engineering exosomes for pancreatic cancer-targeting therapies. Exosomes are emerging as promising nanocarriers for drug and gene delivery due to the unique properties of these naturally derived, nanoscale extracellular vesicles and their innate ability to shuttle proteins, lipids, and polynucleotides (DNA and RNA) between cells. However, substantial challenges in their application still exist, include their inability to target tumor cells and their rapid clearance by the mononuclear phagocyte system (MPS) of the liver and spleen. To this end, Dr. Liu's research team has developed smart exosomes that enable active PDAC targeting while enhances evasion of the mononuclear phagocytotic system, thereby signficantly reducing the liver and spleen clearance and enhancing cytotoxic therapeutic effects on PDAC.

The current award will support his pre-clinical studies in mice to delineate the pharmacokinetics/pharmacodynamics and biodistribution profiles of the smart exosomes, to evalute their efficacy as advanced drug carriers for PDAC therapy in multiple mouse models. Furthermore, a smart exosome library, offering distinct exosome designs for personalized cancer treatment, will be constructed to advance precision PDAC-targeting therapies. Collectively, these activities, will broadly impact the field in developing innovative nanocarriers with optimized cargos and surfaces that holds great translational potential for precision PDAC treatments.

The studies will be pursued in collaboration with an interdisciplinary team of 兔子先生传媒文化作品 faculty, including Drs. JianTing Zhang, JingYuan Liu, Yakov Lapitsky, Lauren Stanoszek, William Gunning and Andrea Kalinoski from Departments of Cell & Cancer Biology, Medicine, Chemical Engineering, Pathology and University of Toledo's Integrated Core Facilities, respectively.
Dean's Update: Monday, October 16, 2023

4th Year Cell & Cancer Biology Student, Christopher Figy, Publishes an Article in Toledo Blade听 听

Chris Figy, is a Ph.D. student in the Cell and Cancer Biology track of our Biomedical Science Program. He recently wrote a column in the Toledo Blade discussing his research on mitosis regulators in cancer cells. He is conducting his research in the laboratory of Dr. Kam Yeung.听听

鈥淢y research is focused on a cellular protein that helps to regulate mitosis called RKIP. We now know that the process of mitosis in cancer cells is faster without RKIP expression. We have used a mouse model to compare the growth rate of breast cancer with and without RKIP expressed. Our research has shown that tumors without RKIP grow faster. Our research has also shown that cancer cells with RKIP expression eventually lose RKIP expression as they grow. Others have observed that less RKIP expression is associated with a more severe diagnosis in some cancers.鈥澨�听
Dean's Update: Monday, October 2, 2023

Congratulations Dr. Zhang!

Please join us in congratulating Dr. J.T. Zhang, who has accepted the position of Interim Senior Associate Dean for Research.

Dr. Zhang completed his B.Sc. degree in Biochemistry from Nanjing University in China. He completed his Ph.D. degree in Molecular and Cell Biology from State University of New York. He joined 兔子先生传媒文化作品 in February 2019 after 21 years of service at Indiana University School of Medicine and is currently chair of our Department of Cell and Cancer Biology.

Dr. Zhang is a recipient of numerous awards, including being elected as a Fellow of the American Association for the Advancement of Science (AAAS) in recognition of his extraordinary research achievements. The fellowship is a lifetime honor accorded by the AAAS. This is one of the most prestigious awards among academic researchers worldwide.

Dr. Zhang has been continuously funded for the past 30 years and studies the mechanisms of drug resistance in cancer chemotherapy with an aim of identifying new targets and therapeutics for more effective cancer treatment. He also studies the genetics of tumor development with work focusing on investigating the potential benefits of drugs that have already been approved by the U.S. Food and Drug Administration (FDA) to treat cancer, either on their own or by circumventing resistance to standard treatments. His recent work in collaboration with other basic and physician scientists includes bioinformatics approaches to test hypothesis using large publicly available patient databases and clinical trials, with the goal of repurposing FDA approved drugs, and in-silico screening of library-sourced compounds in combination with medicinal chemistry for discovery of new cancer drugs.听
Dean's Update: Monday, August 14, 2023

Welcome 2023 Biomedical Science Graduate Program Cell and Cancer Biology Students听 听 听 听 听听

We would like to welcome the 2023 first year students in the Biomedical Sciences Cell & Cancer Biology track.听 The annual Lab Coat Ceremony was held for our new Biomedical Science students on September 7, 2023, where they were presented fresh, white lab coats and were welcomed by Dr. Christopher Cooper and Dr. Kandace Williams (COMLS Deans),听 Dr. Patricia Metting (COMLS Alumni Board and Professor Emerita), fellow students, faculty and staff.听 Best wishes for a successful student career here at the University of Toledo College of Medicine & Life Sciences.
Pictured left to right: Rahul Verma, Ahmad Hegazi, Sushma Khatri, and Prisca Njoku

听

听

听

Congratulations Dr. Raman on your promotion to Associate Professor with Tenure!

听

听

听

ASBMB Interview with Dr. Shang Su

听

The American Society for Biochemistry and Molecular Biology's interviewed Dr. Shang Su in June 2023 as part of their Amplifying API Voices Postdoc Member Interviews program.听 Dr. Su is a postdoctoral fellow in the laboratory of Dr. Xiaohong Li and studying prostate cancer and tumor dormancy in cancer bone metastasis. You can watch the video interview
Great presentation Dr. Su!

听

Congratulations to Cell & Cancer Biology 2023 Ph.D.'s

Congratulations to Dr. Veani Rosale Fernando and Dr. Joshua Letson on receiving their Doctorate of Philosophy in Biomedical Sciences, Cell & Cancer Biology degrees. Their advisor, Dr. Saori Furuta, hooded her students and Dr.听 Kam Yeung served as an academic advisor on the students' committees.

Pictured left to right: Dr. Kam Yeung, Dr. Veani Roshale Fernando, Dr. Joshua Letson, Dr. Saori Furuta

听

Congratulations to Dr. Kandace Williams on receiving the University Women's Commission 36th Annual Award

Congratulations to Kandace Williams, Ph.D., Professor of Cell & Cancer Biology, Senior Associate Dean, College of Graduate Studies, who was recently honored with the Alice H. Skeens Outstanding Woman Award from the University Women's Commission (UWC). The UWC established its Outstanding Woman Award in 1987. Numerous women have been honored since its founding. Stephanie Pannell, M.D., Assistant Professor of Surgery and Associate Chief Medical Officer also received the 2023 award.

In 2011, the UWC Outstanding Woman Award was re-named the Alice H. Skeens Outstanding Woman Award to honor the life of a prolific leader who served our university for nearly five decades as a professor, administrator and advisor. An advocate for students, employees and women, Dr. Skeens was actively involved in numerous campus committees and organizations ranging from student affairs and athletics to Faculty Senate. At the time of her passing, Dr. Skeens held the distinction of having the longest tenure at 兔子先生传媒文化作品 and was serving as the Dean of the College of Language, Literature and Social Sciences, now the College of Arts and Letters. Dr. Skeens steadfastly supported the mission and vision of the UWC and was the Chair of the Scholarship Committee. The UWC continuously strives to continue her vision by promoting scholarships for women and recognizing outstanding service and leadership at 兔子先生传媒文化作品.听 Congratulations Dr. Williams!

Dr. Raman Awarded $2 Million Grant to Study Aggressive Breast Cancer

Congratulations to Dr. Dayanidhi Raman who was recently awarded a 5 year, $2 million grant from the National Cancer Institute, to study triple-negative breast cancer, one of the most lethal, aggressive forms of breast cancer.听 This type of breast cancer is generally receptive to conventional chemotherapy, but the problem is that anti-cancer drugs often stop working which allow the cancer to return and spread. Dr. Raman reasons that chemotherapy cannot get to the small subset of cancer-stem-like cells deep in the tumor. Those cells, which have survived and grown immune to existing treatment, allow the cancer to reemerge and progress unchecked.听 Read the story in the .

Congratulations to Veani Roshale Fernando for 1st place win!

Update: Roshale finished in the top 10 of 144 participants at the Chicago competition.听 Outstanding Roshale!
On December 8, 2022, Ms. Veani Roshale Fernando was awarded first place for her talk at the University of Toledo听 3MT (Three Minute Thesis) Competition presenting her talk "Fighting Breast Cancer Pain-Free."听 She had good competition and placed first receiving a cash prize and all-expenses paid trip to participate in the next round of the competition in Chicago, IL, March 31, 2023.听 The 3MT Competition is an academic competition developed by the University of Queensland, Australia in 2008.听 Since that time, the competition has grown to be held in over 600 institutions and 65 countries.听 The goal of the 3MT is for research students from all departments and colleges to cultivate the ability to explain their research, including both breadth and significance, in a language appropriate to an audience containing both specialists and non-specialists within three minutes.

Roshale also competed in the Elevator Speech Contest at the 2022 ASCB Cell Biology meeting, finishing as Runner-Up.听 The elevator speech is the same premise as the 3MT except participants only have one minute to sell their science.听 Great job Roshale!!

听

听

听

听 听 听Congratulations Dr. Eisenmann on your promotion to Professor in July 2022!




Cell and Cancer Biology Students Place First and Second at the 2022 Graduate Research Forum


Roshale Fernando, current PhD candidate, placed first in the oral presentations at the Graduate Research Forum held听 March 16-17, 2022.听 Her talk was entitled "Sepiapterin Mediates Immunogenic Shift in Breast Cancer via Reprogramming of Tumor-Associated Macrophages."听 Roshale is a 4th year student in Dr. Saori Furuta's lab.





Sayani Bhattacharjee, current PhD candidate, placed second in the oral presentations at the Graduate Research Forum.听 She spoke on "Targeting MCTs to overcome Enzalutamide Resistance in Prostate Cancer." Sayani is a 5th year student in Dr. Nagalakshmi Nadiminty's lab.

Cell and Cancer Biology Student Articles Published in the Toledo Blade

The Toledo Blade is publishing a听 series of articles written by Biomedical Sciences students here at the University of Toledo College of Medicine & Life Sciences.听 Following is the series by our Cell and Cancer Biology students:

• Augustine Kwabil (10/13/25) -
• Rejina Shrestha (9/2/25) -
• Azeezat Osikoya (3/3/25) -
• Christopher Figy (10/2/23) -
• Shreya Ganguly (4/3/23) -
• Deepti Gurung (10/3/22) -
• Jackson Huang (6/6/22) -
• V. Roshale Fernando (6/7/21) -
• Yetunde Makinwa (1/4/21) -
• Justin Fortune Creeden (12/7/20) -
• Sayani Bhattacharjee (10/5/20) -
• Kathryn Becker (7/6/20) -
• Joshua Letson (4/6/20) -
• Sangita Sridharan (3/2/20) -
• Yashna Walia (12/2/19) -
• Cory Howard (7/1/19) -
• Augustus Tilley (10/1/18) -
• Kaitlyn Dvorak (7/2/18) -
• Kalpana Gardiyawasam (03/05/18) -
• Zehui (Lesley) Li (12/31/17) -
• Shengnan Du (9/2/16) -
• Kari Lavik (4/4/16) -

听

2023-2024 Thesis Defense

	CONGRATULATIONS to Deepti Gurung, Ph.D. Ms. Deepti Gurung successfully defended her dissertation for the Ph.D. degree on July 15, 2025. Her dissertation, entitled 鈥淎 Mechanistic Study to Understand the Differential Conformational Dynamics of 14-3-3 Proteins Towards the Development of Isoform-Specific Cancer Therapeutics,鈥� was completed under the mentorship of Dr. JingYuan Jasmine Liu.听
	CONGRATULATIONS to Shruti Ghai, Ph.D. On December 5, 2024, Ms. Shruti Ghai successfully defended her dissertation for her PhD degree. The dissertation was entitled "HSF1 inhibition induces pancreatic ductal adenocarcinoma autophagy through JNK". Dr. Ghai has been mentored by Dr. Kuo-Hui Su.听
	CONGRATULATIONS to Shreyasi Ganguly, M.S. Ms. Ganguly successfully defended her dissertation on May 8, 2024, entitled "Targeting the Thioesterase Domain of FASN using Lansoprazole Derivatives in Triple Negative Breast Cancer Cells". She was mentored by Dr. JianTing Zhang.
	听CONGRATULATIONS to Caoqinglong 'Jackson' Huang, Ph.D. Dr. Huang successfully defended his dissertation entitled "Development of Improved Survivin Dimerization Inhibitors for Castration-resistant Prostate Cancer" on Wednesday, February 14, 2024. Dr. Huang was mentored by Dr. JianTing Zhang.

Cell and Cancer Biology graduates

听